Combining retatrutide with other agents that affect gut motility, such as opioids or anticholinergic drugs, could worsen these effects or alter the absorption of orally administered medications
GLP-1 medications provide significant heart protection by reducing inflammation, improving cholesterol profiles, and lowering the risk of heart failure and stroke
We walk you through everythingfrom timelines to expectationsso youre never guessing
Clinical trial results for Setmelanotide in patients with rare genetic variants Between February 2017 and September 2018, single-arm, open-label multicenter phase 3 trials were conducted at 10 different centers, both in the United States and internationally, to evaluate the efficacy and safety of Setmelanotide therapy
This positive effect can be demonstrated in the reduction of butyrate-producing bacteria observed in the gut microbiota of individuals with type 2 diabetes (T2DM) and other energy-associated metabolic alterations